Using gas-liquid chromatography, we measured free mannose in the serum of six nondiabetic patients with autopsy-proven invasive candidiasis. In all patients serum mannose concentrations were higher than mannose levels found in serum from normal adults and children or from patients with catheter-associated candidemia, mucosal candidiasis, and other mycoses. Spinal fluid from two patients with Candida meningitis showed increased free mannose as compared to seven non-mflammatory spinal fluid samples. However, free mannose in the serum of poorly controlled diabetics (blood glucose of -300 mg/dl) did overlap concentrations in patients with invasive candidiasis. In vitro culture of Candida albicans demonstrated increasing concentrations of mannose associated with growth of the organism. We conclude that physical and chemical assay for mannose in body fluids may be a useful technique to assist in the diagnosis in invasive candidiasis.
Severe disease produced by Candida species has become an increasing problem during the last decade, although its association with compromised hosts has been recognized for well over a century (2) . High-dosage antibiotic, steroid, and immunosuppressive therapy has significantly contributed to this development (12) and will likely continue to do so. Complicating recognition of this clinical problem is the proclivity of Candida to colonize or cause mild infection of the mucous membranes and skin. Thus, aggressive procedures are often required to obtain a definite diagnosis of invasive candidiasis.
Serological techniques involving Candida antibody detection have been evaluated as diagnostic aids, but the results and the interpretations have been conflicting (4, 5) . Serological procedures for detection of circulating microbial polysaccharides have been shown to be clinically useful in several settings (7, 17) . Studies utilizing gas-liquid chromatography have suggested that patients with invasive candidiasis may be distinguished by having elevated serum concentrations of D-arabinitol (10, 18) and that increased serum mannose concentrations are present in patients with candidemia (14) . In an attempt to confirm the association of elevated serum mannose concentration with invasive candidiasis, we have used gas-liquid chromatography to measure the concentration of free or Unbound mannose was determined by gas-liquid chromatography of the aldononitrile derivative as described previously (15) . A Hewlett-Packard gas-liquid chromatograph equipped with dual flame ionization detectors was used (Hewlett-Packard, Avondale, Pa.) Coiled 1.8-m glass columns (2 mm ID) were packed with 2% neopentyl-glycol-succinate on 80/100-mesh Chromosorb W (HP). With hydroxylamine hydrochloride and acetic anhydride with pyridine used as the solvent, the derivative was prepared, dried, and then reconstituted in trichloromethane with 3 jul injected onto the column. Assays were performed in duplicate. The area under the mannose curve was integrated and converted to micrograms of mannose per milliliter of serum by using a standard curve. Day-to-day reproducibilities of between 2 and 12% for mannose were attainable for quantitites of 100 to 900 ng. The sensitivity was such that 10 mg/liter could be detected in a 0.1-ml sample of serum.
RESULTS
The in vitro production of mannose in broth culture of C. albicans is shown in Fig. 1 Concentrations of mannose found in the seven "normal" CSF specimens ranged from 0 to 10.5 ,ug/ml with a mean value of 3.1 ,ug/ml (data not shown). Two of our six patients had histological and cultural evidence for C. albicans meningitis. In one of these (patient no. 6) the serum concentration of free mannose was considerably less (49.4 itg/ml) than in our other five patients, while CSF mannose was modestly elevated. This may reflect the autopsy findings that only the meninges were involved with the Candida infection. Patient no. 4, our other patient with central nervous system candidiasis but with higher serum and CSF mannose values than no. 6, had grossly more extensive central nervous system involvement with multiple Candida brain abscesses in addition to meningitis.
Serum from patients with non-Candida mycoses showed mannose values that were less than those seen with systemic candidiasis (mean, 16.8 ,ug/ml). Evidence has been presented showing increased concentrations of total blood mannose (including glycoproteins) in patients with breast carcinoma (16) . We measured free serum mannose in four patients with metastatic breast carcinoma and found concentrations to be only slightly above those of normal blood donors (mean, 8.2 ,ug/ml).
Sera were obtained from 32 consecutive patients admitted to the Veterans Administration Medical Center intensive care unit. This group was comprised primarily of patients having ischemic heart disease, renal insufficiency, and respiratory failure with or without pulmonary infection. These patients were receiving a variety of pharmacological agents including anti-arrhythmic drugs and antimicrobial agents. Ail four patients with renal insufficiency had mannose concentrations less than 20 ,g/ml and did . l not overlap with patients having systemic candidiasis. With the exception of one patient in diabetic ketoacidosis, the intensive care patients had a mean maximum mannose concentration of 13.4 ,g/ml of serum. Because the patient in ketoacidosis was found to have a serum mannose concentration of 46 ,ug/ml, we carried out a preliminary evaluation of serum from 30 diabetic patients. Only in poorly controlled diabetic patients (glucose of 2300 mg/dl) were mannose concentrations found which overlapped values found in candidiasis patients. Hemoglobin Ac values were not available for these patients. None of our patients with invasive candidiasis was known to be diabetic.
DISCUSSION
The presence of circulating Candida antigen was first reported by Axelsen and Kirkpatrick in a patient with chronic mucocutaneous candidiasis (1). Using anti-Candida antibodies coupled to agarose, Fischer et al. (6) reported the detection of a Candida polysaccharide from the sera of 6 of 23 children with chronic mucocutaneous candidiasis. Miller and co-workers (14) noted a unique gas chromatograph "fingerprint" in patients with blood cultures positive for C. albicans. They suggested that the unique peaks were derivatives of mannose, consistent with the high percentage of mannose-containing compounds known to be present in the cell wall of C. albicans (3). Kiehn and colleagues (10) have used gas chromatography to describe D-arabinitol in the sera of patients with invasive candidiasis. They found 15 (19) . Weiner and Coats-Stephens have developed a radioimmunoassay for Candida mannan and detected antigenemia in 6 of 14 patients with invasive candidiasis (22) .
Kerkering and co-workers have demonstrated a Candida polysaccharide antigen in eight patients with invasive disease by using counterimmunoelectrophoresis (9), whereas Lehmann and Reiss were unable to detect Candida peptidoglucomannan in six patients with systemic candidiasis by using immunodiffusion, counterimmunoelectrophoresis, and enzyme-linked immunosorbent assay (11) .
We present data that quantitation of free mannose identified all six patients with invasive candidiasis. Five of the six tissue-proven cases had markedly elevated serum concentrations, and two patients had increased CSF concentrations. Although a larger variety and number of CSF specimens must be evaluated, our present data suggest that increased free CSF mannose concentrations may accompany Candida involvement of the central nervous system.
Of the two patients with less definite evidence for invasive candidiasis, one had elevated concentrations of mannose which decreased with amphotericin B therapy and the return of peripheral neutrophils. This is consistent with the known antigenic similarity of C. tropicalis and C. albicans (8) .
The mannose assay also qualitatively distinguished patients with mucosal infection and catheter colonization from those with invasive disease. It should be noted, however, that only two patients with catheter candidiasis were evaluated. Patients with renal insufficiency did not have mannose values overlapping those of patients with candidiasis. Likewise, there was no correlation between mannose concentration and renal insufficiency in the patients described in Table 1 . Thus far, poorly controlled diabetics are the only patients who have been found to have elevated mannose concentrations similar to those of patients with systemic candidiasis. No evidence of infection with Candida or other fungi could be found in these diabetic patients.
As a physicochemical assay, our method avoids some problems inherent with immunoassays for antigen. Wheat and co-workers (24) have recently reported their inability to consistently demonstrate antigenemia in patients with staphylococcal endocarditis by using a radioimmunoassay, presumably a result of preexisting antibodies forming immune complexes. Preexisting antibodies to Candida sp. might have a similar effect on sensitivity of immunoassays for Candida antigen, although acid-heat extraction of serum before assay may improve sensitivity VOL. 14, 1981 
